Mary E. White‐Scharf

2.0k citations

49 papers · 1.7k indexed · h-index 23

Transplantation top 2%
Immunology top 5%
- T-cell and B-cell Immunology 19
- Immune Cell Function and Interaction 10
Virology top 5%
- HIV Research and Treatment 5
Genetics top 5%
- Virus-based gene therapy research 13
- Animal Genetics and Reproduction 6
Surgery top 5%
- Xenotransplantation and immune response 21
Molecular Biology
- Viral Infectious Diseases and Gene Expression in Insects 6
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 6

Co-authors: Thereza Imanishi‐Kari David H. Sachs Michel Awwad M. Basker Léo H. Bühler Aron D. Thall David K. C. Cooper Megan Sykes
Cited by: Transplantation Immunology Virology
Journals: Cell (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (1 paper)
Partner nations: United States Belgium Switzerland

In The Last Decade

Mary E. White‐Scharf

49 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mary E. White‐Scharf

Since Specialization

Citations

This map shows the geographic impact of Mary E. White‐Scharf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. White‐Scharf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. White‐Scharf more than expected).

Fields of papers citing papers by Mary E. White‐Scharf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. White‐Scharf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. White‐Scharf. The network helps show where Mary E. White‐Scharf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mary E. White‐Scharf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary E. White‐Scharf Line = papers co-authored together Mary E. White‐Scharf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model Biology of Blood and Marrow Transplantation ·Rob E. Ploemacher,Kevin W. Johnson,Elwin Rombouts,Kenol Etienne,G R Westerhof,Joachim Baumgart,Mary E. White‐Scharf,Julian D. Down	2004	40
2	Engraftment of retroviral EGFP-transduced bone marrow in mice prevents rejection of EGFP-transgenic skin grafts Molecular Therapy ·Göran Andersson,Maria Denaro,Kevin B. Johnson,Peter Morgan,Angela Sullivan,Stuart L. Houser,Clive Patience,Mary E. White‐Scharf,Julian D. Down	2003	26
3	Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells Transplantation ·Leo B hler,Barbara Kurilla-Mahon,Qing Chang,Abraham Sonny,Ian P.J. Alwayn,James Z. Appel,Dawne Newman,Michel Awwad,Mary E. White‐Scharf,Robert Sackstein,David H. Sachs,David K. C. Cooper,Julian D. Down	2002	6
4	DEPLETION OF ANTI-GAL ANTIBODIES IN BABOONS BY INTRAVENOUS THERAPY WITH BOVINE SERUM ALBUMIN CONJUGATED TO GAL OLIGOSACCHARIDES Transplantation ·Katsunori Teranishi,Bernd Gollackner,Léo H. Bühler,Christoph Knosalla,L. Correa,J. D. Down,Mary E. White‐Scharf,David H. Sachs,Michel Awwad,David K. C. Cooper	2002	34
5	PIG HEMATOPOIETIC CELL CHIMERISM IN BABOONS CONDITIONED WITH A NONMYELOABLATIVE REGIMEN AND CD154 BLOCKADE1 Transplantation ·Léo H. Bühler,Michel Awwad,S. Treter,Qing Chang,M. Basker,I.P.J. Alwayn,Katsunori Teranishi,Thomas Ericsson,Kathleen Moran,David J. Harper,Barbara Kurilla-Mahon,Christene A. Huang,Robert Sackstein,Megan Sykes,Mary E. White‐Scharf,David H. Sachs,J. D. Down,David K. C. Cooper	2002	42
6	Expression of xenogeneic MHC class II molecules in HLA‐DR⁺ and ‐DR^– cells: influence of retrovirus vector design and cellular context Xenotransplantation ·Maria Denaro,Donna Kolber‐Simonds,Victoria Schad,Shanthini Muthukumar,Sharon Germana,Mary E. White‐Scharf,Papia T. Banerjee,Christian LeGuern,Göran Andersson	2002	4
7	Porcine hematopoiesis on primate stroma in long-term cultures: enhanced growth with neutralizing tumor necrosis factor-?? and tumor growth factor-?? antibodies Transplantation ·Maria Giovino,Julian D. Down,John D. Jackson,Megan Sykes,Rodney L. Monroy,Mary E. White‐Scharf	2002	5
8	PIG KIDNEY TRANSPLANTATION IN BABOONS: Anti-Gal??1-3Gal IgM Alone Is Associated with Acute Humoral Xenograft Rejection and Disseminated Intravascular Coagulation1 Transplantation ·Léo H. Bühler,Kazuhiko Yamada,Hiroshi Kitamura,Ian P.J. Alwayn,M. Basker,James Z. Appel,Robert B. Colvin,Mary E. White‐Scharf,David H. Sachs,Simon C. Robson,Michel Awwad,David K. C. Cooper	2001	93
9	Miniature swine and hDAF pig kidney transplantation in baboons treated with a nonmyeloablative regimen and CD154 blockade Transplantation Proceedings ·Léo H. Bühler,Kenneth M. Yamada,I.P.J. Alwayn,Hiroshi Kitamura,M. Basker,Rolf N. Barth,James Z. Appel,Michel Awwad,Aron D. Thall,Mary E. White‐Scharf,Daniela Sachs,D. K. C. Cooper	2001	11
10	Induction of kidney allograft tolerance through mixed chimerism in miniature swine Transplantation Proceedings ·Yasushi Fuchimoto,Christene A. Huang,Kazuhiko Yamada,Zachary L. Gleit,Hiroshi Kitamura,Adam Griesemer,Rachel Scheier-Dolberg,Elizabeth Melendy,Mary E. White‐Scharf,David H. Sachs	2001	6
11	Effects of specific anti‐B and/or anti‐plasma cell immunotherapy on antibody production in baboons: depletion of CD20‐ and CD22‐positive B cells does not result in significantly decreased production of  anti‐αGal antibody Xenotransplantation ·Ian P.J. Alwayn,Yuanxin Xu,M. Basker,Cecelia Wu,Léo H. Bühler,Denis Lambrigts,S. Treter,David J. Harper,Hiroshi Kitamura,Ellen S. Vitetta,Abraham Sonny,Michel Awwad,Mary E. White‐Scharf,David H. Sachs,Aron D. Thall,David K. C. Cooper	2001	53
12	Mixed chimerism using a nonmyelosuppressive regimen in miniature swine Transplantation Proceedings ·Yasushi Fuchimoto,Chichi Huang,Zachary L. Gleit,Hiroshi Kitamura,Adam Griesemer,Elizabeth Melendy,Rachel Scheier-Dolberg,Mary E. White‐Scharf,David H. Sachs	2001	3
13	Increases in autologous hematopoietic progenitors in the blood of baboons following irradiation and treatment with porcine stem cell factor and interleukin-3 Transplantation Proceedings ·J. D. Down,Michel Awwad,Barbara Kurilla-Mahon,Kathleen Moran,Thomas Ericsson,Beth A. Oldmixon,Avery LaChance,Alan G. Watts,S. Treter,Kevin Nash,Satoshi Gojo,David H. Sachs,Mary E. White‐Scharf,David K. C. Cooper	2000	3
14	A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons Transplantation Proceedings ·Léo H. Bühler,Michel Awwad,M. Basker,Satoshi Gojo,Aron D. Thall,J. D. Down,Megan Sykes,David Andrews,Robert Sackstein,Mary E. White‐Scharf,David H. Sachs,David K.C. Cooper	2000	5
15	CYTOKINE-MOBILIZED PERIPHERAL BLOOD PROGENITOR CELLS FOR ALLOGENEIC RECONSTITUTION OF MINIATURE SWINE 1 Transplantation ·Christine Colby,Qing Chang,Yasushi Fuchimoto,Vincent R. Ferrara,Michael C. Murphy,Robert Sackstein,Thomas R. Spitzer,Mary E. White‐Scharf,David H. Sachs	2000	22
16	Prevention of rejection with BTI-322 after renal transplantation (results at 9 months) Transplantation Proceedings ·T. Besse,Jacques Malaise,Michel Mourad,Yves Pirson,J. Hope,Michel Awwad,Mary E. White‐Scharf,J.P. Squifflet	1997	11
17	An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2⁺ human T cells in vitro International Immunology ·Dominique Latinne,Bernardo De La Parra,Yannick Nizet,Anne Cornet,Valérie Giovino-Barry,Rodney L. Monroy,Mary E. White‐Scharf,Hervé Bazin	1996	33
18	Synergistic Inhibition of HIV-1 by CD4 Binding Domain Reagents and V3-Directed Monoclonal Antibodies Virology ·Barbara Potts,Keith G. Field,Yaming Wu,Marshall R. Posner,Lisa A. Cavacini,Mary E. White‐Scharf	1993	31
19	Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. The Journal of Immunology ·Miriam C. Souroujon,Mary E. White‐Scharf,J André-Schwartz,M L Gefter,R S Schwartz	1988	96
20	Heavy chain variable region. Multiple gene segments encode anti-4-(hydroxy-3-nitro-phenyl)acetyl idiotypic antibodies. The Journal of Experimental Medicine ·M E Boersch-Supan,Supreet Agarwal,Mary E. White‐Scharf,Thereza Imanishi‐Kari	1985	58

About Mary E. White‐Scharf

Mary E. White‐Scharf is a scholar working on Transplantation, Immunology and Virology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Xenotransplantation and immune response (21 papers), T-cell and B-cell Immunology (19 papers), Virus-based gene therapy research (13 papers), Immune Cell Function and Interaction (10 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Animal Genetics and Reproduction (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Transplantation (160 citations), Immunology (573 citations) and Virology (109 citations). Mary E. White‐Scharf has collaborated with scholars based in United States, Belgium and Switzerland. Frequent co-authors include Thereza Imanishi‐Kari, David H. Sachs, Michel Awwad, M. Basker, Léo H. Bühler, Aron D. Thall, David K. C. Cooper, Megan Sykes, Alfred L.M. Bothwell and Dennis Y. Loh. Their work appears in journals such as Cell, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact